CLBS Chart
- 52-Week Range: $0.41 - $1.22
- Market Capitalization: $30.91M
- Short Percentage: 0%
- Target Price: $4.50
- Shares Outstanding: 60.58M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CLBS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata TherapeuticsGlobeNewsWire | September 15th
- Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata TherapeuticsGlobeNewsWire | September 14th
- Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha | August 4th
- Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire | August 4th
- Caladrius Biosciences to Present at the BIO International Convention 2022GlobeNewsWire | June 8th
- Caladrius Biosciences to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 18th
Company Info
Website: https://www.caladrius.com
Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920
Sector: Healthcare
Industry: Biotechnology
Full time employees: 27
Address: 110 Allen Road, Basking Ridge, NJ, United States, 07920
Sector: Healthcare
Industry: Biotechnology
Full time employees: 27
$CLBS Price target here?
$CLBS the end is near
$CLBS nearing a decent swing entry point
$CLBS Time to buy here
$CLBS wtf is that dump
$CLBS MAY RIP TOMORROW
$CLBS I gave in! Bought more 100 shares
$CLBS power hour will be fucking crazy
$CLBS LETS GOOOOOOOO!!!!!!!
$CLBS go green today and we gap up tomrrow